Ultravist 240
Ultravist 240 is an originator product from Bayer (Schweiz) AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 40.65 to CHF 40.65 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Bayer (Schweiz) AG
- ATC code
- V08AB05
- IT group
- 14.01.13 Niederosmolare nicht-ionische Monomere
- Active substances
- Iodum
- Preparation type
- Originator product
- On the SL since
- 15/03/1994
- Last price change
- 01/12/2024
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Inj Lös 240 mg/ml 50 ml Fl | 1 Stk | CHF 22.26 | CHF 40.65 | 01/01/2024 | B | 7680469690047 |
Limitation
No limitation is recorded on the SL for this preparation.
More preparations in this group
FAQ
Is Ultravist 240 covered by Swiss health insurance?
Yes. Ultravist 240 is on the FOPH Specialities List, so Swiss mandatory health insurance reimburses it within the authorised indication. You still pay the deductible and a co-payment of 10 per cent.
What does Ultravist 240 cost in Switzerland?
The public price is the maximum price set by the FOPH and for Ultravist 240 ranges from CHF 40.65 to CHF 40.65 per pack. The ex-factory price ranges from CHF 22.26 to CHF 22.26. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages